Cargando…
Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
BACKGROUND AND PURPOSE: Several studies have shown the effectiveness of screening programs in decreasing the costs and disutility of type-2 diabetes and related complications. As there is a growth in the incidence of type-2 diabetes amongst the Iranian population, the cost-effectiveness of performin...
Autores principales: | Amirsadri, Mohammadreza, Torkpour, Elahe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976058/ https://www.ncbi.nlm.nih.gov/pubmed/36873274 http://dx.doi.org/10.4103/1735-5362.367799 |
Ejemplares similares
-
Cost-Effectiveness and Cost–Utility Analysis of the Use of Clopidogrel and Pantoprazole in Comparison with Clopidogrel and Omeprazole for the Secondary Prevention of Myocardial Infarction in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2021) -
Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men
por: Amirsadri, Mohammadreza, et al.
Publicado: (2015) -
Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2017) -
154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?
por: Amirsadri, Mohammadreza, et al.
Publicado: (2017) -
Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
por: Jalkanen, Kari, et al.
Publicado: (2021)